Rad things we’ve done

News

Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs

Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck

Harvard spinout lands $40M to bring in vivo drug discovery to cancer

George Church startup Manifold Bio raises $40m for ‘protein barcoding’ technology to improve drug testing

Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform

Protein therapeutics biotech using 'protein barcodes' in drug development secures new financing — led by Jeff Huber

Back in the Manifold: George Church-founded protein therapeutics biotech tacks on $40M in series A funds

Manifold Bio Raises Seed Round to Bring Massively Multiplexed Measurement to Drug Discovery

Could protein barcodes speed up drug development?